ERBB2 and invasive ductal breast carcinoma: Histopathological analysis revealed invasive ductal carcinoma, not otherwise specified (NOS), grade 1, with strong estrogen and progesterone receptor expression (ER+/PR+ >90%), HER2-negative status, and a low Ki-67 proliferation index (10%).